PT  - JOURNAL ARTICLE
AU  - Smith, Jeffrey S.
AU  - Hanseler, Haley
AU  - Welle, John
AU  - Rattray, Rogan
AU  - Campbell, Mary
AU  - Brotherton, Tacy
AU  - Moudgil, Tarsem
AU  - Pack, Thomas F.
AU  - Wegmann, Keith
AU  - Jensen, Shawn
AU  - Jin, Justin S.
AU  - Bifulco, Carlo B.
AU  - Fox, Bernard A.
AU  - Stucky, Nicholas L.
TI  - Effect of various decontamination procedures on disposable N95 mask integrity and SARS-CoV-2 infectivity
AID  - 10.1101/2020.04.11.20062331
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.04.11.20062331
4099  - http://medrxiv.org/content/early/2020/04/15/2020.04.11.20062331.short
4100  - http://medrxiv.org/content/early/2020/04/15/2020.04.11.20062331.full
AB  - The COVID-19 pandemic has created a high demand on personal protective equipment, including disposable N95 masks. Given the need for mask reuse, we tested the feasibility of vaporized hydrogen peroxide (VHP), ultraviolet light (UV), and ethanol decontamination strategies on N95 mask integrity and the ability to remove the infectious potential of SARS-CoV-2. FIT test data showed functional degradation by both ethanol and UV decontamination to different degrees. VHP treated masks showed no significant change in function after two treatments. We also report a single SARS-CoV-2 virucidal experiment using Vero E6 cell infection. We hope our data will guide further research for evidenced-based decisions for disposable N95 mask reuse and help protect caregivers from SARS-CoV-2 and other pathogens.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received to support this work.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data will be available upon reasonable request.